Hopemark Health

Hopemark Health, based in the US, focuses on developing innovative healthcare solutions aimed at improving patient outcomes and streamlining healthcare delivery through advanced telehealth and health management systems. Founded in 2016 in Oak Brook, US, Hopemark Health specializes in healthcare technology solutions. The company has successfully completed one funding deal, raising USD 1. 5 mn in an Add-on round from Brainsway Ltd on May 18, 2026.

Hopemark Health has not undergone any significant pivots in its business strategy or operations since its inception. Hopemark Health specializes in developing innovative healthcare solutions aimed at enhancing patient outcomes and streamlining healthcare delivery. Their core product offerings include advanced telehealth platforms and comprehensive health management systems designed for remote patient monitoring, telemedicine consultations, and data analytics for healthcare providers. Their solutions specifically address challenges in healthcare accessibility, particularly in underserved areas, and chronic condition management.

The company primarily serves hospitals, clinics, and individual healthcare practitioners, with offerings tailored for B2B and B2C markets, available in North America and select European markets. Hopemark Health generates revenue through a diverse structure encompassing subscription-based models, direct sales to healthcare institutions, and collaborations with insurance providers. Revenue streams typically consist of software licensing fees and ongoing service agreements for their healthcare solutions. Clients can choose annual subscription plans that provide access to their telehealth platform and associated services, ensuring continuous support and updates.

Their pricing strategy accommodates various client needs, with tiered pricing based on service levels and user numbers. The flagship offerings contribute significantly to their revenue, underscoring their role in providing efficient healthcare technology. Hopemark Health plans to leverage recent funding to accelerate growth and expand its mental healthcare treatment services. The USD 1.

5 mn investment from Brainsway Ltd will be utilized to bolster new product development, targeting enhanced telehealth services aimed at mental health. The company is also looking to penetrate additional markets, focusing on expanding its footprint in Europe by the end of 2027, thereby meeting the rising demand for digital health solutions.